Form 8-K - Current report:
SEC Accession No. 0001193125-25-027362
Filing Date
2025-02-14
Accepted
2025-02-14 17:06:41
Documents
20
Period of Report
2025-02-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d891468d8k.htm   iXBRL 8-K 37242
2 EX-4.1 d891468dex41.htm EX-4.1 595217
6 GRAPHIC g891468st59.jpg GRAPHIC 3070
7 GRAPHIC g891468st60.jpg GRAPHIC 3477
8 GRAPHIC g891468st61.jpg GRAPHIC 3495
9 GRAPHIC g891468st62.jpg GRAPHIC 3544
10 GRAPHIC g891468st63.jpg GRAPHIC 2951
11 GRAPHIC g891468st64.jpg GRAPHIC 5225
  Complete submission text file 0001193125-25-027362.txt   901080

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gh-20250214.xsd EX-101.SCH 2853
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gh-20250214_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gh-20250214_pre.xml EX-101.PRE 10816
22 EXTRACTED XBRL INSTANCE DOCUMENT d891468d8k_htm.xml XML 3496
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 25630693
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)